Indication
Recurrent Transformed Mycosis Fungoides
1 clinical trial
2 products
Clinical trial
A Phase I Study of Romidepsin in Combination With Parsaclisib in Relapsed and Refractory T-Cell LymphomasStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Product
ParsaclisibProduct
Romidepsin